Quantcast
Channel: MabVax
Browsing all 101 articles
Browse latest View live

MabVax Therapeutics HuMab 5B1 Antibody Featured in Five Presentations at the...

View Article



MabVax Therapeutics Completes Manufacturing of HuMab 5B1 for Upcoming Phase I...

View Article

MabVax Therapeutics Files IND for Phase I Clinical Trial with HuMab 5B1 as a...

Enrollment Expected to Begin in Early 2016

View Article

MabVax Therapeutics Announces FDA Authorization to Proceed with HuMab-5B1 in...

Patient Enrollment in Phase I Trial Expected to Begin in Early 2016

View Article

MabVax Therapeutics Files IND for a Phase I Clinical Trial with 89Zr-HuMab-5B1

Enrollment in Trial with New PET Imaging Agent Expected to Begin in Early 2016

View Article


MabVax Therapeutics Holdings Executes a Debt Facility for up to $10 million

View Article

MabVax Therapeutics Receives FDA Authorization for Phase I Clinical Trial...

Phase I Trials with HuMab-5B1 as Imaging Agent and Therapeutic Treatment Expected to Begin in the First Quarter of 2016

View Article

MabVax Therapeutics to Present at BIO CEO & Investor Conference

View Article


MabVax Therapeutics Holdings Announces New Board Member

View Article


MabVax Therapeutics to Present at the ROTH Conference

View Article

MabVax Therapeutics Initiates Phase I Trial of HuMab-5B1 for Treatment of...

HuMab-5B1 is a Fully Human Antibody With Remarkable Preclinical Specificity and Antitumor Activity Against Pancreatic Cancer

View Article

MabVax Therapeutics Holdings Hires Paul Resnick, M.D. as Chief Business Officer

View Article

MabVax Therapeutics' Fully Human Antibody Approach to Cancer Therapeutics and...

View Article


MabVax Therapeutics' HuMab-5B1 Cancer Therapeutic Featured in Presentation at...

View Article

MabVax Therapeutics' Antibody Discovery Platform and HuMab-5B1 Cancer...

View Article


MabVax Therapeutics Expands Patient Enrollment in Phase I Trial for Treatment...

View Article

MabVax Therapeutics Launches Second Investigational Site with Sarah Cannon...

View Article


MabVax Therapeutics Initiates Patient Enrollment in a Phase I Trial for a New...

View Article

MabVax Therapeutics Announces Uplisting to The Nasdaq Capital Market and...

View Article

MabVax Therapeutics Announces the Closing of its Public Offering

View Article
Browsing all 101 articles
Browse latest View live




Latest Images